Inhibition of human UDP-glucuronosyltransferase enzymes by lapatinib, pazopanib, regorafenib and sorafenib: Implications for hyperbilirubinemia

John Miners, Nuy Chau, Andrew Rowland, Kushari Burns, Ross McKinnon, Peter Mackenzie, Geoffrey Tucker, Kathleen Knights, Ganessan Kichenadasse

    Research output: Contribution to journal › Article › peer-review

    90 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Inhibition of human UDP-glucuronosyltransferase enzymes by lapatinib, pazopanib, regorafenib and sorafenib: Implications for hyperbilirubinemia'. Together they form a unique fingerprint.

    Pharmacology, Toxicology and Pharmaceutical Science